rs142905621

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP3BP4_StrongBP6BS1BS2

The NM_001692.4(ATP6V1B1):​c.1394G>A​(p.Arg465His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00166 in 1,613,912 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R465P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0031 ( 7 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 29 hom. )

Consequence

ATP6V1B1
NM_001692.4 missense

Scores

10
6
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:11

Conservation

PhyloP100: 10.0

Publications

14 publications found
Variant links:
Genes affected
ATP6V1B1 (HGNC:853): (ATPase H+ transporting V1 subunit B1) This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c'', and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This encoded protein is one of two V1 domain B subunit isoforms and is found in the kidney. Mutations in this gene cause distal renal tubular acidosis associated with sensorineural deafness. [provided by RefSeq, Jul 2008]
VAX2 (HGNC:12661): (ventral anterior homeobox 2) This gene encodes a homeobox protein and is almost exclusively expressed in the ventral portion of the retina during development. In mouse studies, this gene was found to be required for the correct formation of the optic fissure and other aspects of retinal development. [provided by RefSeq, Sep 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 9: AlphaMissense, BayesDel_noAF, Cadd, Dann, Eigen, MutationAssessor, phyloP100way_vertebrate, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.0092583).
BP6
Variant 2-70964973-G-A is Benign according to our data. Variant chr2-70964973-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 178290.We mark this variant Benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00307 (468/152266) while in subpopulation SAS AF = 0.0168 (81/4832). AF 95% confidence interval is 0.0138. There are 7 homozygotes in GnomAd4. There are 238 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP6V1B1NM_001692.4 linkc.1394G>A p.Arg465His missense_variant Exon 14 of 14 ENST00000234396.10 NP_001683.2 P15313
ATP6V1B1XM_011532907.3 linkc.1514G>A p.Arg505His missense_variant Exon 13 of 13 XP_011531209.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP6V1B1ENST00000234396.10 linkc.1394G>A p.Arg465His missense_variant Exon 14 of 14 1 NM_001692.4 ENSP00000234396.4 P15313
ENSG00000258881ENST00000606025.5 linkc.476-22540C>T intron_variant Intron 5 of 5 5 ENSP00000475641.1 U3KQ87

Frequencies

GnomAD3 genomes
AF:
0.00306
AC:
466
AN:
152148
Hom.:
7
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00760
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00579
Gnomad SAS
AF:
0.0163
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00301
AC:
757
AN:
251130
AF XY:
0.00373
show subpopulations
Gnomad AFR exome
AF:
0.00862
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00413
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000264
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00151
AC:
2204
AN:
1461646
Hom.:
29
Cov.:
33
AF XY:
0.00194
AC XY:
1412
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.00765
AC:
256
AN:
33480
American (AMR)
AF:
0.000313
AC:
14
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00597
AC:
237
AN:
39700
South Asian (SAS)
AF:
0.0153
AC:
1324
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53182
Middle Eastern (MID)
AF:
0.00347
AC:
20
AN:
5768
European-Non Finnish (NFE)
AF:
0.000170
AC:
189
AN:
1112006
Other (OTH)
AF:
0.00272
AC:
164
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
186
371
557
742
928
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00307
AC:
468
AN:
152266
Hom.:
7
Cov.:
31
AF XY:
0.00320
AC XY:
238
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00758
AC:
315
AN:
41546
American (AMR)
AF:
0.00118
AC:
18
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00580
AC:
30
AN:
5172
South Asian (SAS)
AF:
0.0168
AC:
81
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68020
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
19
38
58
77
96
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00130
Hom.:
4
Bravo
AF:
0.00277
ESP6500AA
AF:
0.00681
AC:
30
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00344
AC:
418
Asia WGS
AF:
0.0140
AC:
50
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000415

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:11
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Renal tubular acidosis with progressive nerve deafness Uncertain:1Benign:5
May 18, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

The heterozygous p.Arg465His variant in ATP6V1B1 has been identified in a German individual with renal tubular acidosis and no other potentially causal variant identified in the gene (PMID: 12579397), but has also been identified in >1% of South Asian chromosomes and 6 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for autosomal recessive renal tubular acidosis. -

Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:reference population

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not specified Benign:3
Jan 22, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg465His in Exon 14 of ATP6V1B1: This variant is not expected to have clinical significance because it has been identified in 0.8% (30/3738) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs142905621). -

not provided Benign:3
Jul 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27535533, 12579397, 26920127) -

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ATP6V1B1: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.73
BayesDel_addAF
Uncertain
0.026
T
BayesDel_noAF
Pathogenic
0.28
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.80
D;.;.
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Pathogenic
1.0
D;D;D
MetaRNN
Benign
0.0093
T;T;T
MetaSVM
Uncertain
0.40
D
MutationAssessor
Pathogenic
3.5
H;.;.
PhyloP100
10
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-3.4
D;D;.
REVEL
Pathogenic
0.83
Sift
Pathogenic
0.0
D;D;.
Sift4G
Uncertain
0.022
D;D;.
Polyphen
1.0
D;D;.
Vest4
0.81
MVP
0.96
MPC
1.1
ClinPred
0.067
T
GERP RS
3.8
Varity_R
0.74
gMVP
0.76
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142905621; hg19: chr2-71192103; API